BTRMF yields 1737.62% · PFE yields 6.13%● Live data
📍 BTRMF pulled ahead of the other in Year 1
Combined, BTRMF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BTRMF + PFE for your $10,000?
Battery Mineral Resources Corp. engages in acquisition, exploration, and development of battery mineral properties for lithium-ion battery and energy storage sector in Canada, the United States, Chile, and South Korea. It primarily explores for cobalt, gold, copper, lithium, and graphite minerals. The company holds interests in the Cobalt District Exploration project consisting of mineral claims and leases covering an aggregate of 100,674 hectares in Ontario and 1,813 hectares in Quebec. It also holds 100% interests in the Bonanza Project in Idaho and Amargosa Project in Nevada; Geumam and Taehwa projects located in South Korea; and the Punitaqui Mining Complex in the Coquimbo region of Chile. In addition, the company leases and sells padding machine, a backfill separation machine to mainline pipeline, renewables and utility construction, and oilfield pipeline and construction contractors. Battery Mineral Resources Corp. is headquartered in Vancouver, Canada.
Full BTRMF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.